Your browser doesn't support javascript.
loading
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib.
Brunetti, Oronzo; Gnoni, Antonio; Licchetta, Antonella; Longo, Vito; Calabrese, Angela; Argentiero, Antonella; Delcuratolo, Sabina; Solimando, Antonio Giovanni; Casadei-Gardini, Andrea; Silvestris, Nicola.
Afiliación
  • Brunetti O; Medical Oncology Unit, National Cancer Research Centre, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy. dr.oronzo.brunetti@tiscali.it.
  • Gnoni A; Medical Oncology Unit, "S. Cuore di Gesù" Hospital, 73014 Gallipoli, Italy. drgnoni.antonio@libero.it.
  • Licchetta A; Medical Oncology Unit, "S. Cuore di Gesù" Hospital, 73014 Gallipoli, Italy. antonellalicchetta@libero.it.
  • Longo V; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy. vito.longo79@tiscali.it.
  • Calabrese A; Radiology Unit, National Cancer Research Centre, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy. acalabrese22@gmail.com.
  • Argentiero A; Medical Oncology Unit, National Cancer Research Centre, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy. argentieroantonella@gmail.com.
  • Delcuratolo S; Scientific Direction, National Cancer Research Centre, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy. delcuratolo.sa@gmail.com.
  • Solimando AG; Medical Oncology Unit, National Cancer Research Centre, IRCCS Istituto Tumori "Giovanni Paolo II", 70124 Bari, Italy. antoniogiovannisolimando@gmail.com.
  • Casadei-Gardini A; Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine "G. Baccelli", University of Bari Medical School, 70124 Bari, Italy. antoniogiovannisolimando@gmail.com.
  • Silvestris N; Department of Medical Oncology, IstitutoScientifico Romagnolo per Lo Studio e Cura Dei Tumori (IRST) IRCCS, 47014 Meldola, Italy. casadeigardini@gmail.com.
Medicina (Kaunas) ; 55(10)2019 Oct 21.
Article en En | MEDLINE | ID: mdl-31640191

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Sorafenib / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2019 Tipo del documento: Article País de afiliación: Italia